Nova Mentis Life Science Corp.

VANCOUVER, A1 · Biotech · Public

Psychedelic-derived therapeutic compounds and formulations for mental health and neurological disorders

Updated · restartlife.co

Sector
Biotech
Headquarters
VANCOUVER, A1
Latest Form D
$12K, Aug 2020
Total capital
$188K
Grants
—
No SBIR or STTR on record
Sector median 1 award
Raised
$188K
3 Form D · Aug 2020
74 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Below sector median 2 patents

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Private capital raisedForm D · SEC$12,170
Private capital raisedForm D · SEC$88,297
Private capital raisedForm D · SEC$87,543
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1168Neumentum, Inc.—$27M
1169Tioga Pharmaceuticals Inc—$24M
1170KODIAK BP, LLC—$13M
1171Nova Mentis Life Science Corp.—$188K
1172SCYNEXIS, INC.—$5.5M
1173MediSix Therapeutics, Inc.—$35M
1174ISOThrive Inc.—$17M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Keith AndersonDirector
  • Steven FeldmanDirector
  • Doug MacdonellDirector
  • Dr. Aylia MohammadiDirector
  • Kelly PladsonExecutive Officer
  • William RascanDirector · Executive Officer
  • Jamie RobinsonExecutive Officer

Patents

USPTO · 0 granted of 1
  • DIAGNOSING, MONITORING AND TREATING NEUROLOGICAL DISEASE WITH PSYCHOACTIVE TRYPTAMINE DERIVATIVES AND mRNA MEASUREMENTSapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.